Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 7, 2006, Pages 825-828

  Kitaichi, Nobuyoshi ^a   Shimizu, Tadamichi ^a   Honda, Ayumi ^a   Abe, Riichiro ^a   Ohgami, Kazuhiro ^a   Shiratori, Kenji ^a   Shimizu, Hiroshi ^a   Ohno, Shigeaki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allergic conjunctivitis; Atopic dermatitis; Eye; MIF; Serum; Tears

Indexed keywords

CYTOKINE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADOLESCENT; ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; ATOPIC DERMATITIS; CALCULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LACRIMAL FLUID LEVEL; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TWO TAILED TEST;

ADOLESCENT; ADULT; CONJUNCTIVITIS, ALLERGIC; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LACRIMAL APPARATUS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; TEARS;

EID: 33746295141     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0168-3     Document Type: Article

References (25)

1. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnelly T, Bucala R (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 93 (15):7849-7854
2. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365 (6448):756-759
3. Brown FG, Nikolic-Paterson DJ, Chadban SJ, Dowling J, Jose M, Metz CN, Bucala R, Atkins RC (2001) Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Transplantation 71 (12):1777-1783
4. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 3 (10):791-800
5. Cooper KD (1994) Atopic dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 102 (1):128-137
6. David JR (1966) Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56 (1):72-77
7. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ, Bucala R (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3 (3):320-323
8. Holden CA (1993) Atopic dermatitis-messengers, second messengers and cytokines. Clin Exp Dermatol 18 (3):201-207
9. Kanski JJ (2003) Clinical Ophthalmology, a systematic approach, 5th edn. Buttherworth-Heinemann/ Elsevier Science, Edinburgh, UK
10. Kapp A (1995) Atopic dermatitis-the skin manifestation of atopy. Clin Exp Allergy 25 (3):210-219
11. Kitaichi N, Kotake S, Mizue Y, Matsuda H, Onoé K, Nishihira J (2000) Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis. Br J Ophthalmol 84 (12):1423-1425
12. Kitaichi N, Kotake S, Sasamoto Y, Namba K, Matsuda A, Ogasawara K, Onoé K, Matsuda H, Nishihira J (1999) Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci 40 (1):247-250
13. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM, Metz CN, Bucala R, Atkins RC (2000) Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57 (2):499-509
14. Lever R, Turbitt M, Sanderson A, MacKie R (1987) Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 89 (1):4-7
15. Morand EF, Bucala R, Leech M (2003) Macrophage migration inhibitory factor: An emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 48 (2):291-299
16. Niino M, Ogata A, Kikuchi S, Tashiro K, Nishihira J (2000) Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet's disease. J Neurol Sci 179 (S 1-2):127-131
17. Rossi AG, Haslett C, Hirani N, Greening AP, Rahman I, Metz CN, Bucala R, Donnelly SC (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 101 (12):2869-2874
18. Shimizu T, Abe R, Ohkawara A, Mizue Y, Nishihira J (1997). Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun 240 (1):173-178
19. Shimizu T, Abe R, Ohkawara A, Nishihira J (1999) Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immunol 104 (3 Pt 1):659-664
20. Shimizu T, Nishihira J, Mizue Y, Nakamura H, Abe R, Watanabe H, Ohkawara A, Shimizu H (2001) High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 116 (6):989-990
21. Stadler J (1993) Severity scoring of atopic dermatitis: The SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 186 (1):23-31
22. Sustiel A, Rocklin R (1989) T cell responses in allergic rhinitis, asthma and atopic dermatitis. Clin Exp Allergy 19 (1):11-18
23. Uchio E, Ono SY, Ikezawa Z, Ohno S (2000) Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 30 (1):103-109
24. Yamaguchi E, Nishihira J, Shimizu T, Takahashi T, Kitashiro N, Hizawa N, Kamishima K, Kawakami Y (2000) Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy 30 (9):1244-1249
25. Zachary CB, Allen MH, MacDonald DM (1985) In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 112 (2):149-156